Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasm Metastasis 2Hematologic Neoplasms 2Fallopian Tube Neoplasms 2Unspecified Childhood Solid Tumor, Protocol Specific 1Sleep Wake Disorders 1Ovarian Neoplasms 1Malignant Solid Neoplasm 1Lung Neoplasms 1Fatigue 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma in Situ 1Brenner Tumor 1Anxiety Disorders 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Paclitaxel 11Carboplatin 7Cisplatin 5Taxes 4paclitaxel poliglumex 2Topotecan 2Etoposide 2elesclomol 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Watchful Waiting 1VTX-2337 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Observation 1Mitoxantrone 1Methods 1Mental Status and Dementia Tests 1Granisetron 1Educational Status 1Early Intervention, Educational 1Dexamethasone 1Cyclophosphamide 1Counseling 1Chemotherapy, Adjuvant 1Calcium Dobesilate 1Aprepitant 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Brenner Tumor × Early Intervention, Educational × Clear all
NCT00719303 2018-02-19

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

GOG Foundation

Phase 3 Unknown
1,070 enrolled
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡